NCT05700461 2026-03-20
Drug Screening Using Novel IMD in Renal Cell Carcinoma
Brigham and Women's Hospital
Phase 1 Enrolling by invitation
Brigham and Women's Hospital
Harvard Medical School (HMS and HSDM)
Hutom Corp
A2 Biotherapeutics Inc.
University of Aarhus
GenomeDx Biosciences Corp